Andrew Aromando serves as Executive at Ambrx Biopharma, Inc., where they oversee executive responsibilities. Since joining the company, Andrew Aromando has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Dec 11, 2023 involved receiving (via award) 100,000 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Dec 11, 2023 | AMAM | $0 | Award | 100,000 | $N/A | Discretionary |
Andrew Aromando currently holds 109,263 shares of Ambrx Biopharma, Inc. (AMAM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Andrew Aromando has been a net neutral trader of AMAM stock. They have purchased $0 and sold $0 worth of shares.
Andrew Aromando's most recent insider trade was on Dec 11, 2023, when they sold 100,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted